Don’t ignore those niggles, aches, and pains in perimenopause! New study looks at how and why women and healthcare professionals should be aware of, and address, musculoskeletal syndrome during menopause.

Abaloparatide, a new bone-strengthening drug, has been recommended by NICE for postmenopausal women, trans men, and non-binary individuals at high risk of fractures. Available on the NHS within three months, it offers a promising new option to help protect and strengthen bones. A bone-boosting game-changer for thousands!